Synthesis of Chiral N-Nitro-oxazolidin-2-ones and O-(β-Nitraminoalkyl) Carbamates in Liquefied 1,1,1,2-Tetrafluoroethane Medium

Abstract

A convenient synthesis of chiral N-nitro-oxazolidin-2-ones by nitration of α-amino acid derived 1,3-oxazolidin-2-ones containing one or two stereogenic centers with dinitrogen pentoxide in liquefied 1,1,1,2-tetrafluoroethane medium has been developed. The obtained N-nitroheterocycles were converted into enantiomerically pure O-(β-nitraminoalkyl) carbamates by treatment with ammonia or amines in the same solvent. The synthesized N-nitro compounds are slightly toxic in vitro to Human Embryonic Kidney 293 (HEK293) cells.

Key words

nitration - dinitrogen pentoxide - N-nitro-oxazolidin-2-ones - primary nitramines - 1,1,1,2-tetrafluoroethane

Publication History

Received: 02 June 2020

Accepted after revision: 13 July 2020

Article published online:
11 August 2020

• References

• 1 Klapötke TM. Chemistry of High-Energy Materials, 5th ed. Walter de Gruyter; Berlin: 2019: 385
• 2 Meyer R, Köhler J, Homburg A. Explosives, 6th ed. Wiley-VCH; Weinheim: 2007: 430
• 3 Nitric Oxide: Biology and Pathobiology, 3rd ed. Ignarro LJ, Freeman B. Academic Press; London: 2017: 434
• 4 Nitric Oxide Donors: For Pharmaceutical and Biological Applications . Wang PG, Cai TB, Taniguchi N. Wiley-VCH; Weinheim: 2005: 407
• 5 Bansinath M, Arbabha B, Turndorf H, Garg UC. Neurochem. Res. 1993; 18: 1063
• 6 Engin AB, Engin ED, Karakus R, Aral A, Gulbahar O, Engin A. Food Chem. Toxicol. 2017; 109: 465
• 7 Nicotinoid Insecticides and the Nicotinic Acetylcholine Receptor. Yamamoto I, Casida JE. Springer; Tokyo: 1999: 300
• 8 Yang D, Wan C, Xiao Y, Che C, Rui C, Qin Z. RSC Adv. 2018; 8: 1838
• 9 Wagner ED, Osiol J, Mitch WA, Plewa MJ. Environ. Sci. Technol. 2014; 48: 8203
• 10 Falb E, Nudelman A, Hassner A. Synth. Commun. 1993; 23: 2839
• 11 Brnardic EJ, Fraley ME, Garbaccio RM, Layton ME, Sanders JM, Culberson C, Jacobson MA, Magliaro BC, Hutson PH, O’Brien JA, Huszar SL, Uslaner JM, Fillgrove KL, Tang C, Kuo Y, Sur SM, Hartman GD. Bioorg. Med. Chem. Lett. 2010; 20: 3129
• 12 Rami M, Macherla R. US Patent 7879892, 2008
• 13 Madariaga MG, Swindells S. Antimicrob. Agents Chemother. 2007; 51: 1130
• 14 Kaushik А, Heuer AM, Bell DT, Culhane JC, Ebner DC, Parrish N, Ippoliti JT, Lamichhane G. Bioorg. Med. Chem. Lett. 2016; 26: 3572
• 15 Moellering RC. Ann. Intern. Med. 2003; 139: 864
• 16 Vale N. In Biomedical Chemistry: Current Trends and Developments. Walter de Gruyter; Berlin: 2015: 178
• 17 Froestl W. In Advances in Pharmacology, Vol. 58. Academic Press; London: 2010: 19
• 18 Zharkov MN, Kuchurov IV, Fomenkov IV, Tartakovsky VA, Fedyanin IV, Zlotin SG. Synthesis 2017; 49: 1103
• 19 Thermophysical Properties of Fluid Systems; (accessed August 5, 2020) ; http://webbook.nist.gov/chemistry/fluid
• 20 Refrigerants – Environmental Properties. The Engineering ToolBox; (accessed August 5, 2020); https://www.engineeringtoolbox.com/Refrigerants-Environment-Properties-d_1220.html
• 21 Gong C, Yang T, Yang X, Liu Y, Ang W, Tang J, Pi W, Xiong L, Chang Y, Ye W, Wang Z, Luo Y, Zhao X, Wei Y. Nanoscale 2013; 5: 275
• 22 Bruker. APEX-III. Bruker AXS Inc., Madison, Wisconsin, USA, 2018
• 23 Krause L, Herbst-Irmer R, Sheldrick GM, Stalke D. J. Appl. Crystallogr. 2015; 48: 3
• 24 Sheldrick GM. Acta Crystallogr., Sect. A: Found. Crystallogr. 2015; 71: 3
• 25 Sheldrick GM. Acta Crystallogr., Sect. C: Cryst. Struct. Commun. 2015; 71: 3
• 26 Gruenhut NS, Goldfrank M, Cushing ML, Caesar GV, Caesar PD, Shoemaker C. In Inorganic Syntheses, Vol. III. Audrieth LF. McGraw-Hill; New York: 1950: 78
• 27 Mosmann TJ. Immunol. Methods 1983; 65: 55